US Stock MarketDetailed Quotes

CRXT CLARUS THERAPEUTICS HLDGS INC

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Apr 26 09:30 ET
0Market Cap0.00P/E (TTM)

CLARUS THERAPEUTICS HLDGS INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
Assets
Current assets
Cash, cash equivalents and short term investments
86.54%19.17M
--9.14M
265.20%26.42M
265.20%26.42M
--21.95M
--10.28M
--7.23M
--7.23M
-Cash and cash equivalents
86.54%19.17M
--9.14M
265.20%26.42M
265.20%26.42M
--21.95M
--10.28M
--7.23M
--7.23M
Receivables
39.75%8.71M
--8.01M
44.11%6.34M
44.11%6.34M
--6.93M
--6.23M
--4.4M
--4.4M
-Accounts receivable
39.75%8.71M
--8.01M
44.11%6.34M
44.11%6.34M
--6.93M
--6.23M
--4.4M
--4.4M
Inventory
72.16%16.81M
--14.93M
142.68%14.21M
142.68%14.21M
--12.48M
--9.76M
--5.86M
--5.86M
Prepaid assets
111.44%4.2M
--4.38M
153.14%4.67M
153.14%4.67M
--3.89M
--1.99M
--1.85M
--1.85M
Total current assets
73.01%48.88M
--36.46M
167.08%51.64M
167.08%51.64M
--45.26M
--28.25M
--19.34M
--19.34M
Non current assets
Net PPE
-17.81%60K
--67K
1.56%65K
1.56%65K
--66K
--73K
--64K
--64K
-Gross PPE
----
----
12.02%233K
12.02%233K
----
----
--208K
--208K
-Accumulated depreciation
----
----
-16.67%-168K
-16.67%-168K
----
----
---144K
---144K
Total non current assets
-17.81%60K
--67K
1.56%65K
1.56%65K
--66K
--73K
--64K
--64K
Total assets
72.77%48.94M
--36.52M
166.54%51.71M
166.54%51.71M
--45.32M
--28.33M
--19.4M
--19.4M
Liabilities
Current liabilities
Payables
-36.95%8.49M
--14.06M
15.18%13.95M
15.18%13.95M
--15.84M
--13.46M
--12.11M
--12.11M
-accounts payable
-36.95%8.49M
--14.06M
15.18%13.95M
15.18%13.95M
--15.84M
--13.46M
--12.11M
--12.11M
Current accrued expenses
-16.37%7.96M
--10.06M
76.67%6.26M
76.67%6.26M
--6.3M
--9.52M
--3.54M
--3.54M
Current debt and capital lease obligation
-21.04%40.51M
--38.49M
0.88%42.27M
0.88%42.27M
--40.34M
--51.3M
--41.9M
--41.9M
-Current debt
-21.04%40.51M
--38.49M
0.88%42.27M
0.88%42.27M
--40.34M
--51.3M
--41.9M
--41.9M
Current deferred liabilities
184.26%2.98M
--1.98M
35.24%1.59M
35.24%1.59M
--827K
--1.05M
--1.17M
--1.17M
Current liabilities
-19.53%61.81M
--65.95M
10.45%66.06M
10.45%66.06M
--64.38M
--76.81M
--59.81M
--59.81M
Non current liabilities
Long term debt and capital lease obligation
----
----
----
----
----
--108.93M
--87.17M
--87.17M
-Long term debt
----
----
----
----
----
--108.93M
--87.17M
--87.17M
Derivative product liabilities
--197K
--925K
--1.57M
--1.57M
--6.47M
----
--0
--0
Preferred securities outside stock equity
----
----
--0
--0
--0
--197.46M
--198.2M
--198.2M
Total non current liabilities
-99.94%197K
--925K
-99.45%1.57M
-99.45%1.57M
--6.47M
--306.4M
--285.37M
--285.37M
Total liabilities
-83.82%62M
--66.88M
-80.41%67.63M
-80.41%67.63M
--70.85M
--383.21M
--345.18M
--345.18M
Shareholders'equity
Share capital
66.67%5K
--2K
--2K
--2K
--2K
--3K
--0
--0
-common stock
66.67%5K
--2K
--2K
--2K
--2K
--3K
--0
--0
-Preferred stock
--0
--0
--0
--0
----
----
--0
--0
Retained earnings
3.37%-347.22M
---336.53M
1.27%-321.66M
1.27%-321.66M
---317.35M
---359.33M
---325.78M
---325.78M
Paid-in capital
7,420.84%334.15M
--306.17M
--305.73M
--305.73M
--291.83M
--4.44M
--0
--0
Total stockholders'equity
96.32%-13.06M
---30.36M
95.11%-15.92M
95.11%-15.92M
---25.53M
---354.88M
---325.78M
---325.78M
Total equity
96.32%-13.06M
---30.36M
95.11%-15.92M
95.11%-15.92M
---25.53M
---354.88M
---325.78M
---325.78M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020
Assets
Current assets
Cash, cash equivalents and short term investments 86.54%19.17M--9.14M265.20%26.42M265.20%26.42M--21.95M--10.28M--7.23M--7.23M
-Cash and cash equivalents 86.54%19.17M--9.14M265.20%26.42M265.20%26.42M--21.95M--10.28M--7.23M--7.23M
Receivables 39.75%8.71M--8.01M44.11%6.34M44.11%6.34M--6.93M--6.23M--4.4M--4.4M
-Accounts receivable 39.75%8.71M--8.01M44.11%6.34M44.11%6.34M--6.93M--6.23M--4.4M--4.4M
Inventory 72.16%16.81M--14.93M142.68%14.21M142.68%14.21M--12.48M--9.76M--5.86M--5.86M
Prepaid assets 111.44%4.2M--4.38M153.14%4.67M153.14%4.67M--3.89M--1.99M--1.85M--1.85M
Total current assets 73.01%48.88M--36.46M167.08%51.64M167.08%51.64M--45.26M--28.25M--19.34M--19.34M
Non current assets
Net PPE -17.81%60K--67K1.56%65K1.56%65K--66K--73K--64K--64K
-Gross PPE --------12.02%233K12.02%233K----------208K--208K
-Accumulated depreciation ---------16.67%-168K-16.67%-168K-----------144K---144K
Total non current assets -17.81%60K--67K1.56%65K1.56%65K--66K--73K--64K--64K
Total assets 72.77%48.94M--36.52M166.54%51.71M166.54%51.71M--45.32M--28.33M--19.4M--19.4M
Liabilities
Current liabilities
Payables -36.95%8.49M--14.06M15.18%13.95M15.18%13.95M--15.84M--13.46M--12.11M--12.11M
-accounts payable -36.95%8.49M--14.06M15.18%13.95M15.18%13.95M--15.84M--13.46M--12.11M--12.11M
Current accrued expenses -16.37%7.96M--10.06M76.67%6.26M76.67%6.26M--6.3M--9.52M--3.54M--3.54M
Current debt and capital lease obligation -21.04%40.51M--38.49M0.88%42.27M0.88%42.27M--40.34M--51.3M--41.9M--41.9M
-Current debt -21.04%40.51M--38.49M0.88%42.27M0.88%42.27M--40.34M--51.3M--41.9M--41.9M
Current deferred liabilities 184.26%2.98M--1.98M35.24%1.59M35.24%1.59M--827K--1.05M--1.17M--1.17M
Current liabilities -19.53%61.81M--65.95M10.45%66.06M10.45%66.06M--64.38M--76.81M--59.81M--59.81M
Non current liabilities
Long term debt and capital lease obligation ----------------------108.93M--87.17M--87.17M
-Long term debt ----------------------108.93M--87.17M--87.17M
Derivative product liabilities --197K--925K--1.57M--1.57M--6.47M------0--0
Preferred securities outside stock equity ----------0--0--0--197.46M--198.2M--198.2M
Total non current liabilities -99.94%197K--925K-99.45%1.57M-99.45%1.57M--6.47M--306.4M--285.37M--285.37M
Total liabilities -83.82%62M--66.88M-80.41%67.63M-80.41%67.63M--70.85M--383.21M--345.18M--345.18M
Shareholders'equity
Share capital 66.67%5K--2K--2K--2K--2K--3K--0--0
-common stock 66.67%5K--2K--2K--2K--2K--3K--0--0
-Preferred stock --0--0--0--0----------0--0
Retained earnings 3.37%-347.22M---336.53M1.27%-321.66M1.27%-321.66M---317.35M---359.33M---325.78M---325.78M
Paid-in capital 7,420.84%334.15M--306.17M--305.73M--305.73M--291.83M--4.44M--0--0
Total stockholders'equity 96.32%-13.06M---30.36M95.11%-15.92M95.11%-15.92M---25.53M---354.88M---325.78M---325.78M
Total equity 96.32%-13.06M---30.36M95.11%-15.92M95.11%-15.92M---25.53M---354.88M---325.78M---325.78M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes----------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg